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Abstract
Background: Youth with juvenile idiopathic arthritis (JIA) may be at risk of poor cardiovascular health. Circulating
endothelial progenitor cells (EPCs) and circulating endothelial cells (CECs) are markers of cardiovascular repair and
damage, respectively, and respond to exercise. The objectives of this study were to compare resting levels of EPCs
and CECs in JIA and controls, and to assess the effects of distinct types of exercise on EPCs and CECs in JIA and
controls.
Methods: Seven youth with JIA and six controls completed 3 visits. First, aerobic fitness was assessed. Participants
then performed either moderate intensity, continuous exercise (MICE) or high intensity, intermittent exercise (HIIE)
on separate days. Blood samples were collected at the beginning (REST), mid-point (MID) and end of exercise
(POST) for determination of EPCs (CD31+CD34brightCD45dimCD133+) and CECs (CD31brightCD34+CD45−CD133−) by
flow cytometry. Between group differences in EPCs and CECs were examined using two-way ANOVA, followed by
Tukey’s HSD post hoc, where appropriate. Statistical significance set at p≤ 0.05.
Results: Both EPCs and CECs were similar between groups at REST (p = 0.18–0.94). During MICE, EPCs remained
unchanged in JIA (p = 0.95) but increased significantly at POST in controls (REST: 0.91 ± 0.55 × 106 cells/L vs.
POST: 1.53 ± 0.36 × 106 cells/L, p = 0.04). Compared with controls, lower levels of EPCs were observed in JIA at MID
(0.48 ± 0.50 × 106 cells/L vs. 1.10 ± 0.39 × 106 cells/L, p = 0.01) and POST (0.38 ± 0.34 × 106 cells/L vs. 1.53 ± 0.36 × 106
cells/L, p < 0.001) during MICE. No changes were detected in CECs with MICE in JIA and controls (p = 0.69). Neither
EPCs nor CECs were modified with HIIE (p = 0.28–0.69).
Conclusion: Youth with JIA demonstrated a blunted EPC response to MICE when compared with controls. Future
work should examine factors that may increase or normalize EPC mobilization in JIA.
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Background
Children and adolescents with juvenile idiopathic arth-
ritis (JIA) may be at an increased risk of developing poor
cardiovascular health, with early signs of atherosclerosis
manifesting as young as 4 years of age [1, 2]. This find-
ing might be expected given that cardiovascular disease
(CVD) is the leading cause of death among adults with
rheumatoid arthritis (RA), and a number of predisposing
factors for CVD, including chronic inflammation and
low levels of physical activity, are also present on a long-
term basis in JIA [3–6]. In fact, recent evidence suggests
that approximately 41 % of patients with JIA maintain
an active disease state, marked by increased levels of in-
flammation and medication usage, 30 years after disease
onset [7]. Interestingly, the increased incidence of CVD
in adults with RA cannot be solely explained by trad-
itional risk factors, highlighting the need for sensitive
and specific alternative markers of CV health in this
population and in younger patients with JIA [3, 8].
Recent evidence from healthy controls and patients
supports a critical role for two distinct cell populations,
circulating endothelial progenitor cells and circulating
endothelial cells, in CV health [9, 10]. Circulating endo-
thelial progenitor cells (EPCs) are a heterogeneous
population of cells derived from the bone marrow that
contribute to vascular repair and post-natal vasculogen-
esis via paracrine secretion of angiogenic factors or dif-
ferentiation into mature endothelial cells [11, 12].
Concentrations of EPCs are inversely associated with
markers of endothelial dysfunction and are known to
predict occurrence of cardiovascular events [9, 13].
Moreover, EPCs are reduced in numerous pathologic
conditions, including RA [13–17]. Much less is known
about circulating endothelial cells (CECs), which repre-
sent a population of mature endothelial cells shed from
the intima following irreversible structural damage to
the endothelium [18]. Elevated levels of CECs are con-
sistently reported in individuals with known risk factors
for cardiovascular disease, including RA, and may be
predictive of cardiovascular events [10, 13, 19]. Only one
study has assessed EPCs in children with JIA and re-
ported similar concentrations to healthy controls [20].
Conversely, CECs have yet to be assessed in JIA; how-
ever, the available evidence in various clinical popula-
tions suggest that both EPCs and CECs cells may
provide important, clinically relevant insight into CV re-
pair and damage, respectively.
Given the altered EPC and CEC profiles observed in
clinical populations at risk of CVD, identification of
methods to enhance their mobilization may allow for
the development of therapeutic agents to improve CV
remodeling. Exercise may represent one such stimulus
as it has been shown to increase peripheral blood EPCs
in adults and children [21–25]. Specifically, acute bouts
of both high and moderate intensity running in adults
led to similar increases in EPCs of 34–120 % and 20–
163 %, respectively [22]. In healthy children, EPCs have
only been examined in response to an acute bout of high
intensity intermittent cycling, which increased EPCs by
83–170 % [23]. Unlike EPCs, the effect of acute exercise
on CECs has only been examined in two studies of older
adults with CVD with mixed results; however, a negative
association between CECs and habitual physical activity
among healthy children was recently reported [26–28].
Thus, exercise-induced changes in EPCs and CECs re-
quire additional study as one potential mechanism to
enhance CV repair and remodeling, and ultimately im-
pact overall CV health.
To date, no study has examined both resting and
exercise-related changes in EPCs and CECs in JIA or com-
pared the effects of distinct types of exercise on these cells.
As such, the objectives of this study were to: 1) compare
resting levels of EPCs and CECs in youth with JIA and
healthy, age-matched controls; 2) assess the effects of
acute bouts of high intensity and moderate intensity exer-
cise on EPCs and CECs in JIA; and 3) compare exercise-
induced changes in EPCs and CECs in JIA and healthy
controls. Given the high levels of inflammation and low
levels of physical activity and fitness reported in JIA, it is
plausible that they would demonstrate lower levels of
EPCs and elevated CECs at rest compared with their
healthy peers [6, 29]. Further, we hypothesized that spe-
cific episodes of exercise, regardless of intensity, would
lead to a transient increase in EPCs in both JIA and con-
trols. Since CECs are negatively associated with CV health,
and exercise is a potent stimulus to improve CV health,
we hypothesized that acute exercise may transiently de-
crease CECs [18, 30, 31].
Methods
Children with JIA were recruited by a research coord-
inator during their regularly scheduled visit to the
McMaster Children’s Hospital Pediatric Rheumatology
Clinic. All patients were 8 to 17 years of age, and were di-
agnosed with JIA in accordance with the International
League of Associations for Rheumatology criteria [32].
Patients were only excluded from participation if they
did not have a confirmed JIA diagnosis, were diag-
nosed with any other medical condition, or had con-
traindications for exercise, including joint pain or
swelling that would prevent completion of the exercise
tests. They were also excluded if they were currently on
biologic therapy or had received corticosteroid injections
within 3 months of study participation as these treatments
may alter resting EPCs or their precursors [20, 33, 34].
Healthy controls were matched by age to participants with
JIA (within 1 year) and were either friends of participants
with JIA or were recruited from the general community.
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Participants were not matched by sex as our previous
work revealed no sex differences in either EPCs or CECs
[26]. Healthy participants were excluded if they had any
known medical conditions or had a BMI ≥ 85th percentile
for their age, since these might impact EPCs and CECs.
All participants and parents/guardians provided written
informed consent and assent, respectively, prior to enroll-
ment in this study, which was approved by the Hamilton
Health Sciences/Faculty of Health Sciences Research
Ethics Board (REB #08-276).
Study overview
Demographic and disease-related characteristics were re-
trieved by retrospective review of each participant’s
health records. All participants were invited to the Child
Health & Exercise Medicine Program research labora-
tory on 3 occasions. During their first visit, basic an-
thropometric data were collected, including standing
height measured to the nearest 0.1 cm, and weight mea-
sured to the nearest 0.1 kg. This was followed by an as-
sessment of aerobic fitness. During their second visit,
participants performed either a moderate intensity, con-
tinuous cycling exercise (MICE) or a high intensity,
intermittent cycling exercise (HIIE). During their third
visit, participants were asked to perform the exercise
that they did not complete in visit #2. The order of exer-
cises were selected in a randomized, counterbalanced
fashion, such that half of the participants in the JIA and
healthy control groups performed MICE followed by
HIIE, while the other half performed HIIE followed by
MICE. Blood samples were collected to assess EPC and
CEC levels at rest, mid- and immediately post-exercise.
Participants were then provided with an accelerometer
to wear over a 9-day period to assess levels of moderate-
to-vigorous physical activity (MVPA).
Aerobic fitness assessment
Aerobic fitness was assessed using the McMaster All
Out Continuous Progressive test on either a mechanic-
ally or electromagnetically braked cycle ergometer
(Flesich-Metabo, Geneva, Switzerland; Lode Corival,
Lode, The Netherlands, respectively). Progression in this
test was achieved by fixed increases in workload every
2-min, such that the participant’s maximal workload
was achieved by 8- to 12-min. The test was termi-
nated when the participant was no longer able to
maintain the prescribed pedaling cadence of 60-70 rpm,
despite strong verbal encouragement. To assess aerobic
fitness, defined here as the maximal volume of oxygen
consumed over 30-sec ( _VO2peak ), participants were asked
to breathe into a mouthpiece connected to a calibrated
metabolic cart (Care Fusion, Cardinal Health) for deter-
mination of breath-by-breath inspired O2 and expired
CO2. Maximal workload, defined as the peak power
(Ẇpeak) achieved during the test prorated to the time
completed in the last stage, was also determined so as to
normalize the workload for the subsequent cycling tasks.
MICE and HIIE protocols
During visits 2 and 3, participants performed either the
MICE or HIIE protocols on the same cycle ergometer
used in their aerobic fitness assessment. These sessions
were performed at the same time of day, at least 4 days
apart. The MICE protocol consisted of 2 × 30-min bouts
of cycling at 50 % of Ẇpeak, with a 6-min rest between
bouts. The continuous nature of this exercise was de-
signed to mimic traditional adult-based exercise pre-
scriptions that have commonly been utilized in the JIA
population [35, 36]. The HIIE protocol consisted of 6
sets of 4 × 15-sec bouts of cycling at 100 % of Ẇpeak for
a total of 6-min of exercise; participants were given a
1-min rest between bouts, and 6-min rest between
sets. The intermittent, but intense, nature of this ex-
ercise was selected to reflect the typical physical ac-
tivity patterns of children [37].
Physical activity assessment
Each participant was outfitted with an ActiGraph GT1M
accelerometer (The ActiGraph, Pensacola, FL), which is
a small device that provides objective and valid measures
of habitual physical activity in youth [38]. Accelerome-
ters were initialized to sample data in 3-sec intervals.
Participants were instructed to wear the device over the
right hip during all waking hours, with the exception of
water activities, for 9 consecutive days. Levels of MVPA
were determined and reported in minutes per day and
minutes per hour of monitoring time, as previously de-
scribed [26, 38]. Participants were included in the ana-
lyses if they wore the device for ≥ 10 h on ≥ 4 days,
including 1 weekend day.
Blood samples
Participants were instructed to avoid engaging in any
strenuous activity for at least 24 h, and to refrain from
eating and drinking, with the exception of water, for 3 h
prior to arrival to the laboratory. Blood samples during
both MICE and HIIE protocols were collected at rest ap-
proximately 15 min before exercise (REST), at the mid
point of exercise (MID), and immediately at the end of
exercise (POST) from an indwelling catheter placed in
the ante-cubital region of the arm. For each blood sam-
pling time point, 12 mL of whole blood was collected of
which 2 mL were processed for a complete blood count
by the McMaster Core Facility, and the remainder was
stained for determination of EPCs and CECs, as previ-
ously described [26, 39]. Briefly, peripheral blood mono-
nuclear cells (PBMCs) were isolated by density gradient
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centrifugation according to manufacturer protocols
(Histopaque 1077, Sigma-Aldrich). Samples were then in-
cubated with an FcR blocking reagent so as to minimize
non-specific, receptor-mediated antibody binding. This
was followed by a 20-min incubation with antibodies
and conjugated fluorochromes for CD31-FITC, CD34-
APC, CD45-PerCP and CD133-PE. Cells were then
lysed and fixed prior to analysis for EPCs, defined as
CD31+CD45dimCD34brCD133+, and CECs, identified as
CD31brCD45−CD34dimCD133− [26, 39]. Samples were an-
alyzed within 24 h of collection on either a BD LSRII flow
cytometer (2 JIA and 2 matched controls) or a Miltenyi
Biotec MACSQuant flow cytometer. Pilot data from sam-
ples assessed on both units revealed no significant differ-
ences in EPC and CEC counts (Obeid et al., unpublished
observation). All analyses were performed using FlowJo
(Version 8.7 for MacIntosh, Treestar Inc.), and both EPC
and CEC levels are reported as a concentration as well as
a percentage of PBMCs.
Statistical analyses
All variables were assessed for normality using the
Shapiro-Wilk test. Independent sample t-tests were used
to assess differences in anthropometric, fitness, and
physical activity variables between groups. To exam-
ine differences in resting EPCs and CECs, two-way
ANOVAs were performed with group (JIA vs. control)
and day (Visit 2 vs. Visit 3) as factors. The effects of
exercise on EPCs and CECs were compared in JIA
and healthy controls by two-way ANOVA, with time
(REST vs. MID vs. POST) and group (JIA vs. controls) as
factors, for MICE and HIIE separately. Given the previ-
ously reported associations between EPCs, CECs, and
physical activity, ANOVAs were repeated with levels of
MVPA included as a covariate. Two-way ANCOVAs were
also performed using resting EPC and CEC concentrations
as a covariate. Significant main effects and interactions
were further examined using Tukey’s HSD post hoc, with
statistical significance set at p ≤ 0.05. Cohen’s d (ES) was
calculated as a measure of effect size, standardized to the
variance in the control group, where small, medium, and
large effects were defined as 0.2–0.49, 0.5–0.79, and >0.79,
respectively [40]. All statistical analyses were performed in
Statistica (version 10.0, Statsoft, Inc., Tulsa, OK). Data are




Seven patients with JIA and 6 healthy controls com-
pleted this study. Disease-related participant characteris-
tics are presented in Table 1. Participant characteristics,
fitness, and physical activity are compared in children
with JIA and healthy controls in Table 2. _VO2peak , a
measure of aerobic fitness, tended to be lower in JIA vs.
controls, but Wpeak was similar. There were also no dif-
ferences between groups in average time spent in MVPA
per day or per hour.
Resting EPCs and CECs
No differences were observed in resting levels of EPCs
or CECs in youth with JIA compared with healthy con-
trols. This finding was consistent when cells were
expressed as either a proportion of PBMCs or as a con-
centration (p = 0.18–0.94). Mean resting EPC and CEC
values by group are presented in Table 3.
Exercise responses in JIA and healthy controls
While the MICE protocol led to a significant post-
exercise increase in the concentration of EPCs in
healthy controls, these cells remained unaltered in JIA
(group × time F(2, 20) = 5.48, p = 0.01). Both MID
(1.11 ± 0.39 × 106 cells/L) and POST (1.68 ± 0.33 × 106
cells/L) EPCs were significantly higher in healthy con-
trols compared with REST (ES = 1.44, 2.71), MID
(0.48 ± 0.50 × 106 cells/L, p = 0.02–0.04; ES = 1.60, 2.89) and
POST (0.43 ± 0.33 × 106 cells/L, p < 0.01; ES = 1.86, 3.17)
Table 1 Disease-related characteristics of children with JIA
Age (sex) JIA type Disease duration (years) CRP ESR Active joints Medications
I 12.8 (F) Psoriatic 3.8 0.34 6.0 Wrists NSAID
II 10.8 (M) Systemic 6.0 0.05a n/a None None
III 17.4 (M) Oligoarthritis (ANA-, RF+) 14.2 0.75a 6.0 None None
IV 13.8 (M) Polyarthritis (ANA-, RF-) 3.6 2.80 11.0 None Methotrexate
V 11.1 (F) Polyarthritis (ANA-, RF+) 3.6 0.90 15.0 Ankles Methotrexate, Corticosteroid
VI 11.5 (F) Polyarthritis (ANA-, RF-) 7.3 <0.20 9.0 None Methotrexate
VII 16.5 (F) Oligoarthritis (ANA+, RF-) 15.2 n/a n/a None NSAID
ANA Antinuclear Antibody, CRP C-Reactive Protein, ESR Erythrocyte Sedimentation Rate, n/a not available, NSAID Non-Steroidal Anti-Inflammatory Drugs, RF Rheumatoid
Factor. Disease duration was calculated as the date of confirmed diagnosis of arthritis to date of enrollment in the study. CRP values were based on a blood sample
taken at the clinic visit closest to study participation (a CRP was measured from a study visit blood sample since participants did not have any recent clinic visits). Active
Joints refer to joints assessed as tender or swollen by the participant’s rheumatologist at the clinic visit closest to study participation. Medications refer to those taken
regularly by the participant at the time of study completion (Off medication duration: II = 5.0 years, and III = 0.9 years)
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EPCs in JIA. A similar interaction was observed when EPCs
were expressed as a proportion of PBMCs (F(2,20) = 5.11,
p = 0.01; ES = 0.60-2.41; Fig. 1). No changes were detected
in proportions or concentrations of EPCs in response to the
HIIE protocol in either JIA or healthy controls (p = 0.33–
0.38; ES = 0.22–1.13). Moreover, neither the MICE nor
HIIE protocol had an effect on proportions or concentra-
tions of CECs in JIA and healthy controls, as presented in
Fig. 1 (p = 0.28–0.69; ES = 0.08–4.1). These findings were
unchanged when resting concentrations and/or MVPA
were included as covariates in the analyses.
Discussion
This is the first study to compare exercise-induced
changes in EPCs and CECs in children with JIA and
healthy controls. Our findings suggest that similar rest-
ing concentrations and proportions of EPCs and CECs
are present in both groups. During MICE, healthy con-
trols demonstrated a steady increase in EPCs, which was
not observed in participants with JIA. Conversely, CECs
were unaltered in both groups during MICE, and HIIE
had no effect on either CECs or EPCs.
Resting EPC and CEC concentrations were similar in
JIA and controls, which falls in line with the recently re-
ported findings of Rusak et al. in JIA, but differs from
previous studies that showed altered EPC and CEC
levels in children and adults with chronic medical condi-
tions compared with controls [14–17, 20, 41–45]. This
may be related to the fact that our participants with JIA
had a small number of active joints and relatively low
C-reactive protein (CRP) and erythrocyte sedimenta-
tion rates (ESR), which may suggest they also had
lower levels of disease activity at the time of partici-
pation. Data from adults with RA lend additional sup-
port to this finding. More specifically, a comparison of
adults with active RA (disease activity score of ≥ 3.2), low
or inactive RA and healthy controls revealed that only
those with active disease demonstrated significantly im-
paired EPCs (active: 0.026 ± 0.002 % vs. no/low active:
0.052 ± 0.006 % vs. controls: 0.045 ± 0.008 %) [14]. The au-
thors also reported a significant, negative relationship be-
tween EPCs and disease activity score (r = -0.38, p < 0.01)
[14]. Similarly, Egan et al. reported significant negative as-
sociations between EPCs and ESR as well as rheumatoid
factor level, as indicators of inflammation [15]. While the
Table 2 Participant characteristics by group
JIA Control Mean difference (Lower, Upper 95 % CI) P value Effect size
N (Males) 7 (3) 6 (1) n/a n/a n/a
Age (years) 13.4 ± 2.6 14.0 ± 2.3 −0.6 (-3.8, 2.6) 0.67 0.26
Height (cm) 157.5 ± 15.0 162.1 ± 5.2 −4.6 (-20.4, 11.1) 0.53 0.88
Weight (kg) 56.0 ± 16.7 50.1 ± 7.1 5.9 (-11.9, 23.8) 0.48 0.83
_VO2peak (ml/kg/min) 45.6 ± 11.4 57.9 ± 8.3 −12.4 (-25.7, 1.0) 0.07 1.48
Wpeak (W/kg) 3.0 ± 1.0 3.5 ± 0.5 −0.4 (-1.5, 0.7) 0.43 1.00
MVPA (min/d) 35.7 ± 13.0 26.1 ± 9.7 9.6 (-6.3, 25.5) 0.21 0.99
MVPA (min/hr wear time) 4.4 ± 2.0 3.8 ± 1.9 0.6 (-2.0, 3.3) 0.61 0.32
_VO2peak maximal volume of oxygen consumed over 30-sec during the aerobic fitness test, Wpeak peak workload achieved during the aerobic fitness test,
MVPA moderate-to-vigorous physical activity. Mean difference calculated as JIA – control. Statistical significance set at p ≤ 0.05
Table 3 Resting EPC and CEC concentrations in JIA (n = 7) and Controls (n = 5)
JIA Controls Effect size
MICE HIIE MICE HIIE
EPC
% of PBMCs 0.02 ± 0.02 0.02 ± 0.02 0.03 ± 0.02 0.02 ± 0.01 0.25
(0.004, 0.03) (0.003, 0.04) (0.01, 0.05) (0.003, 0.05)
× 106 cells/L 0.55 ± 0.48 0.55 ± 0.50 0.91 ± 0.55 0.79 ± 0.42 0.55
(0.10, 0.99) (0.03, 1.08) (0.22, 1.60) (0.24, 1.83)
CEC
% of PBMCs 0.23 ± 0.26 0.11 ± 0.13 0.20 ± 0.23 0.22 ± 0.22 0.17
(0.01, 0.46) (0.03, 0.24) (0.09, 0.48) (0.33, 0.77)
× 106 cells/L 6.36 ± 9.61 2.85 ± 3.19 6.28 ± 7.24 8.26 ± 8.88 0.37
(2.52, 15.24) (0.49, 6.20) (2.71, 15.28) (13.81, 30.3)
Data are presented as mean ± SD (lower, upper 95 % CI). Effect size calculated in JIA vs. controls, standardized to the pooled SD of the control group
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only study to assess CECs in adults with RA reported
higher concentrations of these cells compared with con-
trols, the 2-fold difference between groups was less than
expected when compared with other disease groups (sys-
temic lupus erythematosus and vasculitis) that demon-
strate 6- to 20-fold higher levels of CECs relative to
controls [10]. The authors reasoned that this was likely re-
lated to low disease activity and drug management in the
RA group [10].
The exact underlying mechanism linking EPCs, CECs,
and disease activity remains unclear but is likely medi-
ated, at least in part, by systemic levels of inflammation
and medication use. Grisar et al. reported that patients
with high levels of tumor necrosis factor alpha (TNF-α)
presented with low EPCs, and when examined according
to medication use, those on anti-TNF therapy demon-
strated similar levels of EPCs to healthy controls [14].
More recently, Rusak et al. found that patients with JIA
treated with a combination of glucocorticoids, metho-
trexate, and anti-TNF therapy presented with reduced
EPCs compared with those treated with either metho-
trexate alone, a combination of methotrexate and gluco-
corticoids, and healthy controls [20]. The pilot nature of
this study did not allow us to examine these factors;
however, it may be important to consider both factors in
future study designs.
Exercise is a potent stimulus to transiently increase
EPCs in adults, whereby a single bout can lead to a 66–
309 % increase in peripheral blood concentrations of
these cells [25]. In children, only two studies have
examined the effect of an acute bout of exercise on EPCs
[23, 46]. Zaldivar et al. assessed healthy, pre- and post-
pubertal males and reported an 83–170 % increase in
EPCs [23]. Conversely, Lau et al. examined youth with
chronic kidney disease and reported no change in EPCs
[46]. In the present study, a single bout of moderate in-
tensity, continuous exercise led to a ~100 % increase in
EPCs in healthy children, but did not elicit any change
in EPCs in participants with JIA. The fact that we were
unable to detect a change in EPCs in JIA may suggest an
impaired mobilization of EPCs from the bone marrow.
In healthy individuals, a number of angiogenic factors
are associated with increased EPC proliferation and
mobilization into the circulation; chief among these is
Vascular Endothelial Growth Factor (VEGF) [47].
Interestingly, elevated VEGF levels are consistently re-
ported in RA, but are not matched by an increase in
EPCs [14, 41, 43, 47]. The mechanisms inhibiting the
commonly reported effects of VEGF on EPCs in RA re-
main unknown. If our participants presented with
chronically elevated VEGF, it is plausible that the
exercise stimulus may not have been sufficient to stimu-
late additional VEGF production to promote EPC
mobilization; however, this cannot be ascertained since
VEGF levels were not assessed. Alternatively, we may
have failed to detect a change in peripheral blood EPCs
Fig. 1 REST, MID- and POST-exercise proportions EPCs and CECs in youth with JIA (n = 7) and healthy controls (n = 5). A significant interaction
was seen for EPCs as a proportion of PBMCs during MICE (a), whereby healthy controls demonstrated an increase in EPCs while EPCs in JIA
remained unchanged. Conversely, HIIE (b) did not alter EPCs in healthy controls or JIA. Similarly, neither MICE (c) nor HIIE (d) had any effect on
CECs in JIA and healthy controls. * significant difference from REST, p = 0.05; a significant difference between JIA and healthy controls, p = 0.05;
b significant difference between JIA and healthy controls, p <0.01
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if they were rapidly taken up by another tissue. In fact,
there is some evidence to suggest that EPCs may be re-
cruited from the peripheral blood into the synovium in
RA [48]. It has been hypothesized that EPCs may be
trapped in the synovium leading to increased synovial
blood vessel formation, recruitment of inflammatory
markers to the affected joints, and a reduced ability for
EPCs to respond to CV damage [43, 48, 49]. Since EPCs
were similar in JIA and healthy controls at rest, it seems
unlikely that an acute bout of exercise would lead to a
substantial increase in EPC recruitment to the synovium.
However, we cannot rule out the possibility that the tim-
ing of our blood samples may have limited our ability to
detect changes in EPCs in JIA. Taken together, our data
suggest that exercise affects EPCs levels differently in
youth with JIA and healthy controls.
Given that short bouts of intense exercise led to sig-
nificant increases in EPCs in the work of Zaldivar et al.,
we anticipated similar increases with our HIIE protocol
[23]. However, we did not detect any changes in EPCs in
either JIA or healthy controls during HIIE. This finding
may be related to the timing of our blood collection (too
early, or too late), which may have missed a peak in
EPCs. It is more likely that the exercise duration of our
HIIE protocol was not sufficient to alter levels of these
cells. In fact, when EPC responses in adults were com-
pared following 30-min of high intensity, 30-min of
moderate intensity, or 10-min of moderate intensity run-
ning, only the 30-min bouts led to similar increases in
EPCs [22].
Neither HIIE nor MICE had any effect on CEC con-
centrations in participants with JIA or healthy controls.
Given that CECs are a population mature endothelial
cells detached from the vasculature following irreparable
damage, they are likely more representative of long-term
dysfunction and cumulative injury to the endothelium
[10]. It is plausible that a single, acute bout of exercise,
regardless of intensity or duration, may not be sufficient
to induce any changes in CEC concentrations. Whether
repeated bouts of exercise can modify CEC concentra-
tions remains to be determined.
A number of limitations should be considered in the
interpretation of our findings. First, this study assessed a
small group of patients with different types of JIA mak-
ing it difficult to determine the generalizability of our re-
sults. However, the majority of the calculated effect sizes
were medium or large, suggesting the reported results
were meaningful, irrespective of sample size. Second,
there is no consensus with respect to the best protocol
and markers for EPC and CEC enumeration [18, 39, 50].
Because of similarities in cell surface markers, there is a
chance that some mature endothelial cells and
hematopoietic stem cells were gated with EPCs and vice
versa. Despite this potential overlap, the high degree of
repeatability and reliability of our EPC (intraclass correl-
ation coefficient, ICC = 0.92 and 0.98, respectively) and
CEC (ICC = 0.96 and 0.82) enumeration protocol lends
support to the sensitivity of our measurements (Obeid,
unpublished observation). Third, our EPCs and CECs re-
sponse profile is limited to 2 time points at MID- and
POST-exercise, which may not reflect the peak response
times of these cells. Finally, we assessed EPC and CEC
concentrations but did not assess their function in the
circulation. Future work should seek to include func-
tional assays given that there may be a disconnect in
the quantity and function of EPCs in adults with
chronic conditions [41, 47, 49].
Conclusion
To our knowledge, this was the first study to simultan-
eously compare EPCs and CECs at rest and in response
to exercise in youth with JIA and healthy controls. Our
results suggest that resting levels of both EPCs and
CECs are similar in JIA and healthy controls. In
addition, EPCs in healthy controls increased by an aver-
age of ~100 % in response to an acute bout of moderate
intensity, continuous cycling but remained unchanged in
JIA. Conversely, high intensity, intermittent exercise had
no effect on either EPCs or CECs in JIA and controls.
The EPC response to exercise in JIA may be blunted as
a result of disease-related inflammation and medication
use, but may also reflect recruitment of EPCs from the
circulation into the synovium. Future studies should ex-
plore factors that may be inhibiting exercise-induced
changes in EPCs, as well as the impact of blood sample
timing on EPC and CEC responses to exercise. Given
the growing body of evidence supporting the role of
these cells in maintaining and improving vascular health,
a better understanding of the effects of exercise on their
concentrations and function may allow for development
of an appropriate adjuvant therapy to maintain CV
health in JIA.
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